Fate Therapeutics

In News

Fate Therapeutics Presents Updated Phase 1 Clinical Data of - GlobeNewswire

GlobeNewswire - Dec 08, 2025

Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts - TipRanks

TipRanks - Nov 17, 2025

Fate Therapeutics (NASDAQ:FATE) Stock Passes Below Two Hundred Day Moving Average - Here's What Happened - MarketBeat

MarketBeat - Dec 06, 2025

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference - Yahoo Finance

Yahoo Finance - Nov 25, 2025

Fate Therapeutics, Inc. Presents Updated Phase 1 Clinical Data of FT819 Off-The-Shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-The-Shelf Car T-Shelf CAR T-Cell Programs - marketscreener.com

marketscreener.com - Dec 08, 2025

Fate Therapeutics reports positive lupus treatment data at ASH meeting By Investing.com - Investing.com Nigeria

Investing.com Nigeria - Dec 08, 2025

Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq

Nasdaq - Nov 13, 2025

Biotech layoffs: Fate, Generation Bio, ORIC trim teams and pipelines - FirstWord Pharma

FirstWord Pharma - Aug 13, 2025

Fate Therapeutics Receives Regulatory Authorization for International Clinical Trials of Off-the-Shelf CAR T-Cell Therapies FT819 and FT836, Expanding Patient Accessibility in Autoimmune and Oncology Indications - Quiver Quantitative

Quiver Quantitative - Nov 13, 2025

Fate Therapeutics presents updated Phase 1 data of FT819 - TipRanks

TipRanks - Dec 08, 2025

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance

Yahoo Finance - Nov 04, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Nov 04, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment